HIMS — Hims & Hers Health Share Price
0.000.00%
Last trade - 00:00- $6.05bn
- $5.75bn
- $1.48bn
- 91
- 18
- 97
- 78
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 39.07 | ||
| PEG Ratio (f) | 2.12 | ||
| EPS Growth (f) | 22.63% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 12.69 | ||
| Price to Tang. Book | 18.87 | ||
| Price to Free Cashflow | 30.5 | ||
| Price to Sales | 4.1 | ||
| EV to EBITDA | 72.77 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 12.73% | ||
| Return on Equity | 30.71% | ||
| Operating Margin | 4.19% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | 271.88 | 526.92 | 872 | 1,476.51 | 2,327.02 | 2,768.56 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | +11.84 | +45.28 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities. Its digital platform enables access to treatments for a range of chronic conditions, including those related to sexual health, hair loss, dermatology, mental health, and weight loss. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate and prescriptions are fulfilled online through licensed pharmacies on a subscription basis. It also offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. Through its mobile applications, consumers can access a range of educational programs, wellness content, and other services.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- January 20th, 2021
- Public Since
- September 9th, 2019
- No. of Shareholders
- 93
- No. of Employees
- 1,637
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- New York Stock Exchange
- Shares in Issue
- 222,165,572
- Address
- 2269 Chestnut St, #523, SAN FRANCISCO, 94123
- Web
- https://www.forhims.com/
- Phone
- +1 4158510195
- Auditors
- KPMG LLP
Upcoming Events for HIMS
Q1 2025 Hims & Hers Health Inc Earnings Call
Hims & Hers Health Inc at JPMorgan Global Technology, Media and Communications Conference
Hims & Hers Health Inc Annual Shareholders Meeting
Q2 2025 Hims & Hers Health Inc Earnings Release
Similar to HIMS
Agilon Health
New York Stock Exchange
AMERICAN WELL
New York Stock Exchange
AMN Healthcare Services
New York Stock Exchange
Ardent Health Partners
New York Stock Exchange
Auna SA
New York Stock Exchange
FAQ
What is the Hims & Hers Health share price?
As of Today at 21:06 UTC, shares in Hims & Hers Health are trading at $27.23. This share price information is delayed by 15 minutes.
How has the Hims & Hers Health share price performed this year?
Shares in Hims & Hers Health last closed at $27.23 and the price had moved by +119.42% over the past 365 days. In terms of relative price strength the Hims & Hers Health share price has outperformed the S&P500 Index by +106.32% over the past year.
What are the analyst and broker recommendations for Hims & Hers Health?
The overall consensus recommendation for Hims & Hers Health is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Hims & Hers Health dividend yield?
Hims & Hers Health does not currently pay a dividend.
Does Hims & Hers Health pay a dividend?
Hims & Hers Health does not currently pay a dividend.
When does Hims & Hers Health next pay dividends?
Hims & Hers Health does not currently pay a dividend.
How do I buy Hims & Hers Health shares?
To buy shares in Hims & Hers Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Hims & Hers Health?
As of the previous close price of $27.23, shares in Hims & Hers Health had a market capitalisation of $6.05bn.
Where are Hims & Hers Health shares listed?
Here are the trading details for Hims & Hers Health:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: HIMS
What kind of share is Hims & Hers Health?
Based on an overall assessment of its quality, value and momentum Hims & Hers Health is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Hims & Hers Health share price forecast for 2025?
The analyst consensus target price for shares in Hims & Hers Health is $44.50. That is 63.42% above the last closing price of $27.23.
Analysts covering Hims & Hers Health currently have a consensus Earnings Per Share (EPS) forecast of $0.61 for the next financial year.
Find out moreWhat is the trend in the Hims & Hers Health share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Hims & Hers Health. Over the past six months, its share price has outperformed the S&P500 Index by +36.23%.
As of the last closing price of $27.23, shares in Hims & Hers Health were trading +2.67% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Hims & Hers Health PE Ratio?
The Hims & Hers Health PE ratio based on its reported earnings over the past 12 months is 39.07. The shares last closed at $27.23.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Hims & Hers Health?
We do not have data on Hims & Hers Health's directors